Hemply Balance, an Enexis portfolio company, announces its intention to list of NGM Nordic SME https://hemplybalance.com/mfn_news/hemply-balance-offentliggor-memorandum-infor-nyemission-av-units-i-samband-med-notering-pa-nordic-sme/

Enexis invests in Foria, a US cannabis and hemp brand in the sexual wellness space https://www.foriawellness.com

Curaleaf to Enter European Cannabis Market with Acquisition of EMMAC Life Sciences Group, an Enexis portfolio company https://www.emmac.com/curaleaf-to-enter-european-cannabis-market-with-acquisition-of-emmac-life-sciences-limited-europes-leading-independent-cannabis-company/

Enexis invests in South West Brands, a multi-brand consumer goods group developed specifically for the CBD industry https://www.southwestbrands.co

Enexis invests in Octarine Bio, a Danish synthetic biology company developing cannabinoid and psilocybin derivatives https://octarinebio.com

Enexis invests in Reyos, a Swiss company designing and coordinating gold clinical trials exploring the medical benefits of the cannabis plant https://reyos.ch

Enexis invests in Infinite Percentage Partners, a biopharmaceutical company dedicated to the discovery, development and commercialization of innovative natural medicines, including cannabis https://ippcares.com

Enexis invests in CanLabs, a California-based cannabis, hemp and CBD testing laboratory operator

Enexis invest in Emmac Life Sciences, a vertically integrated European medical cannabis company https://www.emmac.com